乐普药业股份有限公司
- Country
- Ownership
- -
- Established
- 2010-12-06
- Employees
- -
- Market Cap
- -
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
82
NMPA:82
Drug Approvals
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字H20254029
- Approval Date
- Apr 30, 2025
NMPA
Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（IV）
- Product Name
- 恩格列净二甲双胍缓释片(Ⅳ)
- Approval Number
- 国药准字H20253414
- Approval Date
- Feb 20, 2025
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20253046
- Approval Date
- Jan 2, 2025
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20249141
- Approval Date
- Oct 22, 2024
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20244890
- Approval Date
- Sep 10, 2024
NMPA
Esomeprazole Magnesium Enteric-coated Capsules
- Product Name
- 艾司奥美拉唑镁肠溶胶囊
- Approval Number
- 国药准字H20244324
- Approval Date
- Jun 28, 2024
NMPA
Esomeprazole Magnesium Enteric-coated Capsules
- Product Name
- 艾司奥美拉唑镁肠溶胶囊
- Approval Number
- 国药准字H20244325
- Approval Date
- Jun 28, 2024
NMPA
Nifedipine Controlled-release Tablets
- Product Name
- 硝苯地平控释片
- Approval Number
- 国药准字H20234506
- Approval Date
- Nov 21, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
No trials found
News
No news found